Drug Profile
Monoclonal antibody IRac-ricin A conjugate
Alternative Names: IRac.dgALatest Information Update: 30 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Drug conjugates; Immunotoxins; Monoclonal antibodies
- Mechanism of Action Immunostimulants; Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Hodgkin's disease
Most Recent Events
- 29 May 1997 New profile
- 29 May 1997 Preclinical development for Hodgkin's disease in Germany (Unknown route)
- 29 May 1997 Preclinical development for Hodgkin's disease in United Kingdom (Unknown route)